Companies / AVITA Medical, Inc.

AVITA Medical, Inc.

Nasdaq: RCELCIK 1762303VALENCIA, CAavitamedical.com ↗

Financials · FY2025

Revenue$71.61M
Net income$-48.59M
Total debt$0
Cash$9.14M
Diluted EPS$-1.74
Shares outstanding30.9M

Ownership

30.9M shares outstanding · as of Aug 3, 2026
4.7%10%+ / strategic
Ownership
10%+ / strategic4.67%1,444,579
Institutions141.22%43,673,934
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 6

View all →
Insider% of sharesShares
O'Toole David DFormerCFO
0.46%141,927
McNamara RobertFormerDirector
0.35%108,985
Kelsey NicoleFormerChief Legal Officer
0.32%98,390
Reed Jan SternFormerDirector
0.24%73,225
Cook Jeremy CurnockFormerDirector
0.20%62,050
Woody Joseph FralinFormerDirector
——

Institutional holders 72

View all →
HolderValue% of shares
Orbimed Advisors LLC$42.52M132.72%
Vanguard Group Inc$4.98M4.67%
BlackRock, Inc.$2.33M1.83%
Geode Capital Management, LLC$2.01M1.76%
Northern Trust Corp$563.7K0.53%
State Street Corporation$532.7K0.42%
Morgan Stanley$516.5K0.48%
AQR Capital Management, LLC$349.1K0.31%
Divisadero Street Capital Management, LP$345.0K0.32%
UBS Group AG$311.6K0.29%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 19, 2026O'Toole David D
Executive
BuyCommon Stock$12.4K+3K
+2.19%
140,127
0.45% of shares
low
Mar 11, 2026O'Toole David D
Executive
BuyCommon Stock$8.6K+2K
+1.28%
141,927
0.46% of shares
low
Jan 20, 2026McNamara Robert
Director
GrantStock Options (Right to Buy)—+16K
16,133
0.05% of shares
low
Jan 20, 2026McNamara Robert
Director
GrantCommon Stock—+22K
+25.60%
108,985
0.35% of shares
low
Jan 20, 2026Cook Jeremy Curnock
Director
GrantStock Options (Right to Buy)—+16K
16,133
0.05% of shares
low
Jan 20, 2026Cook Jeremy Curnock
Director
GrantCommon Stock—+22K
+55.76%
62,050
0.20% of shares
low
Jan 20, 2026Reed Jan Stern
Director
GrantStock Options (Right to Buy)—+16K
16,133
0.05% of shares
low
Jan 20, 2026Reed Jan Stern
Director
GrantCommon Stock—+22K
+43.55%
73,225
0.24% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—1,444,579—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
RCELCommon StockEquity05380C102BBG00TD18T43